The global orthopedic biomaterials product market is anticipated to witness a decent growth with a steady CAGR within the forecast period from 2017 to 2025. Transparency Market Research has recently published a report titled, “Orthopedic Biomaterials Product Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 – 2025.” Owing to advancement in technology, the future of biomaterials has now seen the light of the day. Biomaterials are used mostly for implantation on or in human body to administer the drugs conveniently without any pain. It is usually used in treating replacement of human organs or tissues.
Get Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=39632
The global orthopedic biomaterials product market is segmented based on of material type, product, geography, and end-user. On the basis of product, the orthopedic biomaterials product market is divided into hip implants, knee implant, scaffolds, bone substitutes, resorbable products, and so forth. Out of these, hip implant segment is evaluated to account for major share in the market due to increase in number of old age people, increasing cases of injuries with respect to sports, accidents, and adventure, and wide adoption of advanced hip procedures and products.
On the basis of material, the global orthopedic biomaterials product market is classified into ceramic, metallic, polymer, regenerative biomaterials, and natural biomaterial. Among these, the regenerative biomaterials segment is likely to register largest CAGR in coming years due to advancement in technology, supportive government criteria, and increasing awareness about stem cell treatment.
Johnson & Johnson, Zimmer Biomet Holdings Inc., Globus Medical Inc., Wright Medical Technology, Zeus Industrial Products, Inc., Orthofix Holdings, Arthrex Inc., and Medtronic are the key players leading the global orthopedic biomaterials product market.